OBJECTIVES: To investigate the recurrence rate of cholesteatoma using Kaplan-Meier survival analysis. STUDY DESIGN: Retrospective study. SETTING: Tertiary referral center. PATIENTS: Three hundred forty-five patients with middle ear cholesteatoma operated on by the same surgeon between 1987 and 2002. METHODS: The cumulative recurrence rate of cholesteatoma during a 5-year follow-up period was calculated using Kaplan-Meier survival analysis. RESULTS: The overall 5-year recurrence rate was 11.8%. The recurrence rate increased with the follow-up time. The 5-year recurrence rate was 3.9% in patients treated with canal wall down tympanoplasty (CWDT) and 16.7% in patients treated with intact canal wall tympanoplasty (ICWT) or canal wall reconstruction (CWR) after CWDT with a significant difference (p < 0.01). The 5-year recurrence rate was 26.0% in patients operated on between 1987 and 1996 and 0.7% in patients operated on between 1997 and 2002, again with a significant difference (p < 0.001). CONCLUSION: Kaplan-Meier survival analysis should be used for calculating the recurrence rate of cholesteatoma. Although this analytic method further demonstrates that CWDT is a more reliable surgical method than ICWT/CWR in reducing cholesteatoma recurrence, clinical judgment should be exercised, and we continue to recommend that a flexible approach should be adopted in deciding whether to perform CWDT or ICWT/CWR for individual cases.
OBJECTIVES: To investigate the recurrence rate of cholesteatoma using Kaplan-Meier survival analysis. STUDY DESIGN: Retrospective study. SETTING: Tertiary referral center. PATIENTS: Three hundred forty-five patients with middle ear cholesteatoma operated on by the same surgeon between 1987 and 2002. METHODS: The cumulative recurrence rate of cholesteatoma during a 5-year follow-up period was calculated using Kaplan-Meier survival analysis. RESULTS: The overall 5-year recurrence rate was 11.8%. The recurrence rate increased with the follow-up time. The 5-year recurrence rate was 3.9% in patients treated with canal wall down tympanoplasty (CWDT) and 16.7% in patients treated with intact canal wall tympanoplasty (ICWT) or canal wall reconstruction (CWR) after CWDT with a significant difference (p < 0.01). The 5-year recurrence rate was 26.0% in patients operated on between 1987 and 1996 and 0.7% in patients operated on between 1997 and 2002, again with a significant difference (p < 0.001). CONCLUSION: Kaplan-Meier survival analysis should be used for calculating the recurrence rate of cholesteatoma. Although this analytic method further demonstrates that CWDT is a more reliable surgical method than ICWT/CWR in reducing cholesteatoma recurrence, clinical judgment should be exercised, and we continue to recommend that a flexible approach should be adopted in deciding whether to perform CWDT or ICWT/CWR for individual cases.
Authors: Amir Minovi; Johanna Venjacob; Stefan Volkenstein; John Dornhoffer; Stefan Dazert Journal: Eur Arch Otorhinolaryngol Date: 2013-03-26 Impact factor: 2.503